Medicare Enrolled

Dr. Brian Karp, MD

Student in an Organized Health Care Education/Training Program · Philadelphia, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
132 SOUTH 10TH STREET, Philadelphia, PA 19107
2159558900
In practice since 2007 (19 years)
NPI: 1073657409 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Karp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karp? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Karp

Dr. Brian Karp is a student in an organized health care education/training program specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Karp performed 8,204 Medicare services across 676 unique beneficiaries.

Between the years covered by Open Payments, Dr. Karp received a total of $3,678 from 27 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Karp is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in PA $3,678 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,204
Medicare services
Top 1% in PA for student in an organized health care education/training program
676
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~432 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
7,500 $17 $53
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
84 $222 $1,025
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
82 $103 $270
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
76 $80 $645
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
74 $114 $410
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
65 $69 $185
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
64 $65 $120
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
63 $109 $240
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
47 $93 $875
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
38 $40 $85
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
32 $70 $153
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
26 $55 $325
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
26 $90 $270
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
15 $154 $750
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
12 $193 $750
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
91.7% high complexity
1.8% medium
6.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,678
Total received (2018-2024)
Avg $613/year across 6 years
Top 9% in PA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,678 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,991
2023
$1,241
2022
$113
2021
$70
2020
$21
2018
$243

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$522
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$423
Daiichi Sankyo Inc.
$192
Takeda Pharmaceuticals U.S.A., Inc.
$175
Janssen Biotech, Inc.
$131
Madrigal Pharmaceuticals
$118
Regeneron Healthcare Solutions, Inc.
$90
GENZYME CORPORATION
$76
Lilly USA, LLC
$53
Ardelyx, Inc.
$44
QOL Medical, LLC
$37
Phathom Pharmaceuticals, Inc.
$29
Merck Sharp & Dohme LLC
$23
PFIZER INC.
$21
ORPHALAN INC
$14
Mallinckrodt Hospital Products Inc.
$14
Meridian Bioscience Inc.
$14
Celgene Corporation
$14
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$715
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$474
Janssen Biotech, Inc.
$376
Celgene Corporation
$287
Regeneron Healthcare Solutions, Inc.
$260
Takeda Pharmaceuticals U.S.A., Inc.
$259
Daiichi Sankyo Inc.
$255
GENZYME CORPORATION
$168
PFIZER INC.
$128
Madrigal Pharmaceuticals
$118
AbbVie, Inc.
$113
Merck Sharp & Dohme LLC
$76
AbbVie Inc.
$70
Lilly USA, LLC
$53
Ardelyx, Inc.
$44
Mallinckrodt Hospital Products Inc.
$43
QOL Medical, LLC
$37
Phathom Pharmaceuticals, Inc.
$29
Organon LLC
$29
UCB, Inc.
$23
Fresenius Kabi USA, LLC
$22
AIMMUNE THERAPEUTICS, INC.
$18
Evoke Pharma, Inc.
$18
Synergy Pharmaceuticals Inc
$18
INTERCEPT PHARMACEUTICALS, INC.
$17
ORPHALAN INC
$14
Meridian Bioscience Inc.
$14
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
APRISO · CREON · CUVRIOR · Cimzia · DIFICID · DUPIXENT · ENTYVIO · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INJECTAFER · LINZESS · MAVYRET · Mavyret · OCALIVA · OMVOH · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · TERLIVAZ · TREMFYA · TRULANCE · Trulance · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for student in an organized health care education/training program in PA.

Looking for a student in an organized health care education/training program specialist in Philadelphia?
Compare student in an organized health care education/training programs in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
7,621
Per 100K population
481.6
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Karp is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 9% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Karp experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Karp performed 7,500 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karp receive payments from pharmaceutical companies?
Yes. Dr. Karp received a total of $3,678 from 27 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karp's costs compare to other student in an organized health care education/training programs in Philadelphia?
Dr. Karp's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →